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A novel G-protein-coupled receptor was isolated from mouse and rat neuronal and lymphatic tissues. The amino acid sequence of the rat receptor 
(rNLR) shows an overall homology of 80% to a recently cloned receptor from Burkitt’s lymphoma cells (BLRl) which is exclusively expressed 
in lymphatic tissues [(1992) Eur. J Immuno1. 22, 27951. Much less homology between rNLR and BLRl was observed at the N-terminus (about 
40%), whereas rNLR and the mouse homologue mNLR show 92% amino acid identity. Northern blot analysis of NLR revealed a predominant 
5.5 kb mRNA species in various brain regions and neuronal cell lines, whereas in the spleen a 3 kb transcript is predominant. This distribution 
suggests a role of NLR in the nervous and immune systems. 
G-protein-coupled receptor; NLR; NG108-15 cell; Polymerase chain reaction; BLRl; Burkitt’s lymphoma; Interleukin 8 
1. INTRODUCTION spleen but also in various brain areas and in neuronal 
cell lines. 
G-protein-coupled receptors are activated by 
hormones, neurotransmitters or neuropeptides and 
transduce these signals into the cell by specific interac- 
tion with GTP binding proteins. Recent evidence sug- 
gests that some members of the cytokine family also 
produce their effects by interacting with G-protein-cou- 
pled receptors [l]. In particular, interleukin-8 (IL-@, 
which belongs to a family of structurally related cyto- 
kines similar to platet factor 4, exerts its effect through 
a G-protein-coupled receptor [2,3]. Sequence homology 
between the cloned G-protein-coupled receptors indi- 
cates a high degree of similarity of the high- and low- 
affinity IL-8 receptors with the receptors for chemo- 
attractants, such as fMet-Leu-Phe, C5a and, surpris- 
ingly, also for neuropeptide receptors, such as the delta 
opiate receptor (DOR-1) [4], neuropeptide Y-3 receptor 
[5] and the somatostatin-2 receptor [6]. Furthermore, a 
novel member of a G-protein-coupled receptor (BLRl) 
has been cloned from Burkitt’s lymphoma cells with 
37% homology to the low affinity IL-8 receptor and 
shown to be exclusively expressed in lymphatic tissue 
[71- 
2. MATERIALS AND METHODS 
2.1. Poly(A) RNA preparation and Northern blot analysis 
Total RNA was isolated by the acid guanidinium isothiocyanate 
method [8] and poly(A) RNA was selected by QuickPrep columns 
(Pharmacia, Freiburg, Germany). After electrophoresis the RNA was 
blotted onto Nytran membranes (Schleicher & Schiill, Germany) and 
hybridized with a [32P]UTP-labeled cRNA probe according to stand- 
ard methods [9]. 
2.2. Polymerase chain reaction, cloning and sequencing 
Polymerase chain reaction (PCR) to amplify cDNA’s encoding po- 
tential G-protein-coupled receptors was performed as follows: first 
strand cDNA for PCR reaction was generated from 1 pg NG108-15 
cell poly(A) RNA using an oligo(dT) primer and MoMLV reverse 
transcriptase (Superscript, BRL) in 20 ~1 final reaction volume. 1~1 
of reaction was amplified by 30 cycles of PCR [lo] using primers 
derived from transmembrane segments III and VI [l 11. Cycle condi- 
tions were 1.5 min at 95”C, 2 min at 50°C and 2 min at 72°C. The 
resulting products were purified with PrimeErase columns (Strat- 
agene), blunted with Klenow polymerase and cloned into pBhtescript 
(Stratagene). Dideoxynucleotide sequencing was then performed by 
the chain termination method [12] with Sequenase-2.0 (USB). Four 
clones showing the motif of G-protein-coupled receptors were ob- 
tained (561-45, 561-51, 561-39, 561-8). 
In the present study we describe the cloning of NLR, 
a putative G-protein-coupled receptor which exhibits a 
high homology to BLRl and, in contrast to BLRl, is 
expressed not only in lymphatic tissues such as the 
2.3. Library screening and subcloning 
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Clone 561-8 was ‘2P-labe11ed by the random primer technique [13] 
and used as a probe to screen a rat genomic library constructed in 
phage AEMBL3 and a NGIOS-15 hexanucleotide-primed cDNA li- 
brary in lZAP II (custom synthesis by Invitrogen, Heidelberg, Ger- 
many). Out of 5 x IO5 genomic phage recombinants creened, three 
identical clones were isolated and subjected to restriction mapping and 
Southern blot analysis. A 7 kb BamHI fragment containing the full 
coding region was subcloned in pBluescript. Out of 1 x lo6 recombi- 
nant NG108-15 cDNA phages screened only one 3’ truncated clone, 
designated NlS-10, was isolated. 
Published by Elsevier Science Publishers B. V. 173 
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In order to isolate the rat N-terminal Exon (EXl), primer extension 
and second strand synthesis was performed on 1 pug rat spleen mRNA 
with primer SPR-3 (Fig. 1B) according to the protocol of reverse 
transcriptase Superscript (BRL). The resulting products were cloned 
in pBluescript and verified by colony hybridization and sequencing. 
2.4. In situ hybridization 
A sagittal section of rat brain was hybridized with a [‘%]UTP- 
labelled antisense RC8 RNA probe and for control with a sense RNA 
probe, under conditions previously described [14]. 
2.5. Stable expression and ligand binding 
The cDNA clone RC8 was subcloned in pRc/CMV (Invitrogen, 
Heidelberg, Germany) and transfected into CHO-Kl cells by Lipo- 
fectin (BRL). Individual clones were isolated by limiting dilution in 
DMEM-FIZ-medium (BRL) with 600 pg/ml G418. Two clones ex- 
pressing the highest levels of RC8 mRNA were used for binding 
experiments as described [17]. 
3. RESULTS AND DISCUSSION 
Poly(A) RNA from NG108-15 cells, a hybrid cell line 
of mouse N18TG2 neuroblastoma nd rat C6BU-1 gli- 
oma parent cell lines, was subjected to PCR amplifica- 
tion with degenerate primers to transmembrane domain 
III and VI of G-protein-coupled receptors as described 
[ 111. Sequence determination of cloned PCR fragments 
revealed several putative receptor-encoding cDNA 
clones. Clone 561-45 was identical to rat endothelin 1A 
receptor [15] and clone 561-51 shows sequence identity 
to the mouse somatostatin 2 receptor [16]. Screening of 
a NG10815 library with this partial cDNA resulted in 
the cloning of an isoform of the SST2 receptor 
(SSTR2B) [17]. In addition several novel putative recep- 
tor fragments were identified (data not shown). One 
cDNA fragment (561-8) was used as a hybridization 
probe to screen a rat genomic library. Restriction anal- 
ysis of several positive phage clones led to the isolation 
of a 7 kb BumHI fragment named aRG8 (Fig. 1A). This 
fragment contains the coding region from membrane 
domain I-VII plus the stop codon, but lacks a hydro- 
philic N-terminal extracellular domain and a start 
codon, indicating the existence of an intervening se- 
quence. Therefore a cDNA library was constructed 
from rat spleen mRNA by primer extension using a 
Fig. 1. (A) Organization and restriction map of ilRG8 rat genomic 
clone and RC8 rat spleen cDNA clone. The thick line represents 
genomic sequences, the shaded box the exon 2, and the black box the 
exon 1 only present in RC8. RGSint represents an intron-specific 
primer 122 bp upstream of the exon 2 acceptor site used for PCR. (B) 
Nucleotide and amino acid sequence of rNLR as deduced from RC8 
and 1RG8 sequences downstream of the SPR-3 primer. The putative 
membrane-spanning domains are boxed and are assigned on the basis 
of Kyte and Doolittle hydrophobicity plot [25]. Potential N-linked 
glycosylation sites (CHO), potential phosphorylation recognition sites 
(P) [26] and the potential palmitoylation site at the C-terminus (0) are 
indicated. Primers used for reverse transcription (SPR-3) and PCR 
(PCR-Exl. PCR-M3) are marked by a solid line and dashed lines with 
arrows, respectively. The intron-exon junction is marked. 
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Fig. 2. Alignment of amino acid sequences of rNLR and of other G-protein-coupled receptors. Gaps, indicated by hyphens, have been introduced 
to obtain maximum homology. The approximate positions of the transmembrane r gions are indicated by a bold line above the sequences, identical 
amino acids with respect o rNLR are boxed. Highly conserved receptor motifs throughout G-protein-coupled receptors are indicated by dots. The 
sequences are taken from [27] (IL-SRb, low-affinity human interleukin 8 receptor), [19] (IL-SRa, hip-amity human interieukin 8 receptor), [S] 
(NPY3-R, bovine neuro~ptide Y receptor), [6] (rSSTR2, rat somatostatin 2 receptor), [20] (rVATlR, rat vascular type 1 angiotensin II receptor), 
[21] (FMLR, human N-formylpeptide receptor), and [22] (CSAR, human complement Sa receptor). 
;1RG8-specific primer (SPR-3; Fig. IB). Sequencing of 
aRG8-positive colonies revealed a cDNA clone RCS, 
which is identical to the transmembrane domains I-VII 
of lRG8 and has additional sequences at the N-termi- 
nus, including several methionines as putative start 
codons (Fig. 1A). 
The longest open reading frame of RC8 cDNA spec- 
ifies a sequence of 1,122 bp ~o~esponding to a protein 
of 374 amino acids with seven highly hydrophobic re- 
gions (Fig. IB), designated rNLR (rat neurolymphatic 
receptor). The protein sequence of rNLR predicts po- 
tential N-linked glycosylation sites in the N-terminal 
extracellular egion as well as in the second and third 
extracellular loop. In addition, several serine and thre- 
onine residues are located between transmembrane do- 
mains III and IV and within the C-terminal region and 
may represent potential phosphorylation sites. A con- 
served cysteine residue (Fig. lB, residue number 344) 
may function as an acceptor site for pal~toylation [ 181. 
An homology search on protein databases reveals the 
highest similiarity of rNLR to BLRl (SO%), a G-pro- 
tein~oupled receptor recently isolated from Burkitt’s 
lymphoma cells 171 (Fig. 2). In addition, rNLR shows 
significant homologies to the low and high affinity re- 
ceptors for IL8 (IL-SRb, IL-SRa, 37%, 35%)[19], a bo- 
vine neuropeptide Y receptor (NPY3,35%) [5], the vas- 
cular type-l angiotensin II receptor (rVAT II R, 30%) 
[2@] and the rat somatostatin 2 receptor (rSST2R, 26%) 
[6]. rNLR also exhibits similarities to the receptors for 
fMet-Leu-Phe (FMLR, 25%) [21] and human C5a 
anaphylatoxin (CSAR, 24%) [22]. All these receptors 
contain common features, such as the conserved proline 
residues in transmembrane regions IV, V, VI, and VII, 
known to function as helix initiators and thought to 
surround the ligand binding pocket within the mem- 
brane; furthermore cysteine residues are present in the 
second and third extracellular loops, which may be in- 
volved in the formation of disulfide bridges [18J. 
In addition, we have isolated a 3’-truncated cDNA 
clone from a NGlOS-15 library, termed NlS-10, encod- 
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Fig. 3. Amino acid sequence alignment of rNLR (rat), mNLR (mouse) and BLRl(human) [7] in the N-terminal region, including transmembrane 
domains TM1 to TM6. Identical residues with respect o rNLR are indicated by dots, negatively charged amino acids are marked by 8. 
ing for the first 270 amino acids of mNLR, the mouse 
homologue of rNLR. Fig. 3 shows a high overall se- 
quence identity between rNLR and mNLR (92%), 
whereas BLRl revealed a relatively low homology of 
about 40% in the N-terminal extracellular egion com- 
pared to both NLR species. 
The distribution of mNLR and rNLR mRNA was 
examined by Northern blot analysis and PCR (Fig. 4). 
A predominant mRNA of about 5.5 kb along with 
minor transcripts of 3.8 and 3 kb were observed in 
poly(A) RNA from NG108- 15 neuroblastoma x glioma 
A 
hybrid cells and rat pituitary GH3 cells, in various 
mouse brain regions such as the cerebellum and cortex, 
as well as in the liver. In contrast, only a 3 kb mRNA 
species is found in the mouse spleen total RNA and in 
human Raji B cells (Fig. 4A). No signal could be de- 
tected in mouse thymus. This 3 kb transcript in B cells 
and lymphatic tissue is in line with the size of mRNA 
measured for BLRl [7] 
The expression of rNLR mRNA in various rat tissues 
determined by PCR confirms the expression pattern of 
mNLR mRNA (Fig. 4B). In addition to cerebellum and 
size marker 
kb 
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* 
f&j 
- 2.3 
a bcdef g 
a-tubulin 
1Bkb * 
i kl 
Fig. 4. (A) Northern blot analysis of mNLR receptor mRNA in several mouse tissues as well as NGl08-15 and rat pituitary GH3 cell lines. 
3.5 pg aliquots of poly(A) RNA, except 30 pg total mouse spleen and thymus RNA, were subjected to electrophoresis, transferred onto nylon 
membranes and hybridized with a ‘ZP-labelled Nl8-10 cRNA probe. mRNA bands are indicated by arrows. Equal loading and quality of RNA 
was shown by control hybridization with a “P-labelled mouse a-tubulin cRNA as shown on the bottom. HindIII-digested fragments of phage 1 
were used as size markers. Lanes: a, NGl08-15 cells; b, liver; c, striatum; d, midbrain; e, cerebellum; f, cortex; g, ATt20 cells; h, GH3 cells; i, spleen; 
k, thymus; 1, human Raji B cells. (B) PCR analysis of rNLR receptor transcripts in rat tissues. Total RNA was isolated, digested with RQl 
RNase-free DNase I (Promega) and converted to single-stranded cDNA by specific priming of 4 pg total RNA with primer SPR-3 (Fig. 2B) and 
Superscript reverse transcriptase (BRL). cDNAs were amlipified [lo] using Taq polymerase (Pharmacia) and up- and downstream primers PCR-EXl 
and PCR-M3 as indicated in Fig. 2B for 35 cycles (96°C for 1 min, 54°C for 1 min, and 72°C for 1 min), which results in a single cDNA species 
of the expected size (483 bp). Primers flanking the intron region were designed for amplifying cDNA sequences only. No amplification was observed 
using rat genomic DNA as a template in contrast to PCR with an intron-specific primer (RGlint: 5’ CATAGAATAGTGCAAACAAA 3’; for 
approximate position see Fig. 2A), yielding a 605 bp fragment. PCR products were run on 2% agarose gels and stained with ethidium bromide. 
Tissues and cells used are indicated above. HaeIII-digested fragments of 0x174 phage was used as size markers (in bp: 1,353, 1,078,872,603,310, 
281, 271, 234, 194, 118). 
176 
Volume 321, number 2,3 FEBSLETl-ERS April 1993 
Fig. 5. Localization of NLR receptor mRNA by in situ hybridization. 
A sagittal section of rat brain was hybridized with an antisense RC8 
cRNA probe, labelled with [%]UTP. The slices were exposed for 4 
days at -7O’C with an intensifying screen. Areas with specific mRNA 
expression are indicated. CBL, cerebellum; DG, dentate gyrus. Hy- 
bridization with the sense probe shows no specific signals (data not 
shown). 
cortex rNLR is also present in the striatum, the pitui- 
tary and adrenal gland. Since rat C6 glioma cells do not 
express the NLR receptor, the mRNA present in 
NG108-15 mouse neuroblastoma x rat glioma hybrid 
cells appears to derive exclusively from the mouse neu- 
roblastoma parent cell line, N18TG2. 
The existence of NLR mRNA in the brain is also 
demonstrated by in situ hybridization experiments (Fig. 
5). In the sagittal section of a rat brain, hybridization 
signals with an antisense probe were observed predom- 
inantly over cell layers of the cerebellum. In addition, 
a lower expression level is found over the granule cells 
of the dentate gyrus of the hippocampus. This localiza- 
tion of NLR mRNA is in good accordance with the 
observation that neuronal cells, but not glia cells, ex- 
press the receptor in NG108-15 cells. 
Taken together, rNLR and its mouse analogue repre- 
sent putative G-protein-coupled receptors which are ex- 
pressed in neuronal and lymphatic tissue. They share a 
high homology to a recently cloned receptor from 
Burkitt’s lymphoma cells (BLRl) [7] and hybridize to 
the same 3 kb mRNA species in spleen. In other tissues, 
however, a 5.5 kb NLR transcript is predominant. The 
nature of the 5.5 kb mRNA is presently not known. The 
NLR gene, like the BLRl gene, contains an intervening 
sequence between the N-terminus and the first trans- 
membrane domain. In the BLRl gene this intron com- 
prises 9 kb, and a similar intron size has been found for 
the mouse analogue of the gene (M. Lipp, personal 
communication). The possibility of alternatively spliced 
mRNA species within this intron can be excluded, since 
a single amplification product was obtained by PCR 
with intron-flanking primers and cDNAs from rat tis- 
sues and NG108-15 cells. In addition, the N-terminus 
of rNLR which has been cloned from rat spleen, is 
almost identical to the N-terminus of its mouse ana- 
logue, which has been cloned from mouse neuroblas- 
toma cells (N18TG2), indicating that spleen and neu- 
ronal cells may express a NLR mRNA with similar 5 
coding regions. We argue that the 5.5 kb mRNA may 
represent a 5’-extended species, which derives from dif- 
ferent transcription initiation sites of the gene. 
Although rNLR and its mouse analogue share a high 
overall sequence homology to the human BLRl, the 
homology at the N-terminus is much less pronounced 
(Fig. 3). A similar situation is observed in the case of the 
high- and low-affinity IL-8 receptors which exhibit a 
high homology except in the N-terminal region. There- 
fore, we suggest that this N-terminal divergence be- 
tween rat/mouse NLR vs. human BLRl may not reflect 
species differences. Instead NLR and BLRl may repre- 
sent homologous receptors that differ in their affinity 
for a common ligand or have structurally related li- 
gands. This hypothesis is also supported by the observa- 
tion that BLRl has 11 negative amino acid residues in 
the extracellular N-terminus, whereas both rNLR and 
mNLR have 7 negatively charged amino acids (Fig. 3), 
thought to play an important role for the IL-8 receptor 
in binding of the basic ligand [3]. 
In order to determine the ligand for NLR we stably 
expressed the clone, RC8, under the control of the CMV 
promotor in CHO-Kl cells. Two independent clonal 
cell lines expressing the highest level of RC8 mRNA 
(data not shown) were tested for binding with the fol- 
lowing ligands: [3H]CCK-8 (cholecystokinin-8), 
[3H]DADLE (D-Ala-b-Leu-enkephalin), [3H]angioten- 
sin II, [3H]oxytocin and [1251]1 1-Tyr-somatostatin. 
None of these ligands showed binding to either NLR- 
expressing clonal CHO lines. 
The homology of the putative G-protein-coupled re- 
ceptor NLR to both the cytokine and neuropeptide 
family of receptors raises the question of its biological 
importance in neuroimmune connections. Several neu- 
ropeptides, such as neuropeptide Y, calcitonin gene- 
related peptide, galanin and opiods, besides their wide 
distribution throughout the central and peripheral nerv- 
ous system, have been demonstrated to be localized in 
nerve endings innervating lymphoid organs [23]. Inter- 
estingly, neuropeptide Y-positive nerve terminals were 
found in close apposition with lymphoid compartments 
of the rat spleen [24]. Thus, the precise localization of 
NLR expression in the lymphoid compartments of the 
spleen, as well as the identification of its ligand, may 
contribute to our understanding of neuroimmunomod- 
ulation. 
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